Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octenidine lozenges for acute sore throat
2012-002876-15Phase 3Completed
- Sponsor
- Cassella-med
- Start
- Aug 2012
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of octenidine in acute pharyngitis (3 arms), sponsored by Cassella-med. Primary endpoint: Primary responder rate (pain relief and inflammation reduction). Started Aug 2012; status: completed.
02
Drugs
octenidine
03
Conditions
acute pharyngitis
Beyond the preview
Go deeper on 2012-002876-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002876-15.